InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,979.57
(
0.14%
)
Post# of 17403
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

moosedogger

Send PM Follow Ignore
Followers 6
Posts 1085
Boards Moderated 0
Alias Born 07/18/2006

moosedogger

Re: moosedogger post# 12327

Tuesday, 02/16/2021 7:57:24 PM

Tuesday, February 16, 2021 7:57:24 PM

Post# of 17403
Rheumatologists & Nephrologists call continued.........


Fugitive447
Bullish
05:05 PM
5. He took questions. One question was what the care model should be with 2 approved drugs. He said he would be using Lupkynis due to its speed of efficacy and lack of STEROIDS!!!! He did say he can see opportunities or certain circumstances to use Lupkynis along with Benlysta together.

6. Lupkynis will be used for maintenance no question. Also took a question about why not use other legacy CNIs. He said VOC is 4x more powerful and the change made in the drugs make up separate itself significantly from those other drugs. He said more on that but I can't recall at the moment.


Hear from expert rheumatologists and nephrologists as they discuss key clinical information in a live, virtual series

https://lupkynispro.com/speaker-series/

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AUPH News
More AUPH News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!